Država: Južnoafrička Republika
Jezik: engleski
Izvor: South African Health Products Regulatory Authority (SAHPRA)
Smith_kb
AUGMENTIN S (Powder for Suspension) AUGMENTIN SF (Powder for Suspension Forte) SCHEDULING STATUS: S4 PROPRIETARY NAMES (and dosage form): AUGMENTIN S (Powder for Suspension) AUGMENTIN SF (Powder for Suspension Forte) COMPOSITION: Augmentin S: powder for suspension, when reconstituted according to the instructions each 5 mL contains amoxycillin trihydrate B.P. equivalent to 125 mg amoxycillin and potassium clavulanate equivalent to 31,25 mg clavulanic acid . Augmentin SF: powder for suspension forte, when reconstituted according to instructions each 5 mL contains amoxycillin trihydrate B. P. equivalent to 250 mg amoxycillin and potassium clavulanate equivalent to 62,5 mg clavulanic acid. PHARMACOLOGICAL CLASSIFICATION: A.20.1.2 Penicillins PHARMACOLOGICAL ACTION: (a) Bacteriology (i) Spectrum Augmentin is the group name for formulations containing 2, 4 and 5 parts of a broad spectrum penicillin, amoxycillin and 1 part of potassium clavulanate. Potassium clavulanate has been shown in vitro to be an irreversible inhibitor of beta-lactamase produced by: Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Proteus vulgaris, Haemophilus influenzae, Neisseria gonorrhoea and Bacteroides fragilis. Potassium clavulanate does not inactivate the chromosomally mediated (Sykes Type 1 Cephalosporinase) beta-lactamases produced by Acinetobacter species, Citrobacter species, Enterobacter, Indole positive Proteus, Providencia species and Serratia marcescens. In vitro the formulation showed synergism against amoxycillin-resistant organisms, with no evidence of antagonism and the activity was not reduced in the presence of serum. (In vitro activity does not necessarily imply in vivo efficacy.) (ii) Bactericidal action The amoxycillin component of the formulations exert a ba Pročitajte cijeli dokument